Methotrexate Completed Phase N/A Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00121134Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
NCT00615901Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer